| Old Articles: <Older 17281-17290 Newer> |
|---|
 |
The Motley Fool
October 9, 2006
S.J. Caplan |
Scouting the Latest IPOs An investor's roundup of new-issue hits, misses, and no-shows. Danaos Corporation... Breitburn Energy Partners... Acme Packet... eHealth... ImaRX Therapeutics... Light Sciences Oncology... UltraPetrol Bahamas... etc.   |
The Motley Fool
October 9, 2006
Seth Jayson |
GlobeTel: Back to the Minors Investors who are looking in dark places for the next big thing should take a close look at the hard lessons of GlobeTel story. Learn how and why this happened, then govern yourself accordingly. |
The Motley Fool
October 9, 2006
Rich Smith |
All Work and No Play ... All work and no play really is no way to live your life or to invest your money. At least not if you want to beat the market. To bag the 50-baggers, you need to catch superior companies while they're young. |
The Motley Fool
October 9, 2006
Rich Smith |
Foolish Forecast: I Dream of Sealy The mattress maker reports third-quarter 2006 earnings. Investors, do you want to know what Wall Street expects to see? Do you want to know what really matters? |
The Motley Fool
October 9, 2006
Brian Lawler |
Much-Needed Publicity for Millennium Millennium Pharmaceuticals' cancer-fighting drug Velcade is set to gain exposure for a new treatment. Investors, take note. |
The Motley Fool
October 9, 2006
Brian Lawler |
The Commandments of Biotech Investing, Part 2 It's a complex field, but it's not impossible for investors to master. The more in-depth your research of a potential biotech investment, and the more you remember to follow these commandments, the better your potential for success will be when investing in this fascinating field. |
The Motley Fool
October 9, 2006
Brian D. Pacampara |
Buy a Stock, Buy a Business Thinking about stocks as the ownership of real, tangible, and concrete businesses is the first and most crucial factor to investment success. |
The Motley Fool
October 9, 2006
Brian Lawler |
New Drug for New River An approvable letter from the FDA sends shares of New River Pharmaceuticals up. |
The Motley Fool
October 9, 2006
Dan Caplinger |
Be Like Christopher Columbus Investors who ventured beyond America's borders over the past few years have done exceptionally well, outperforming even the bull market here at home that has led to the Dow's recent highs. |
The Motley Fool
October 9, 2006
Rich Smith |
Foolish Forecast: LG.Philips Turns On It's hard to believe in the booming industry for flat-panel TV sets, but LG.Philips lost money last quarter. And analysts are predicting yet another loss when the firm reports its third quarter 2006. Will the TV maker prove them wrong? |
| <Older 17281-17290 Newer> Return to current articles. |
